Cambridge, MA, United States of America

Yu Qian

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yu Qian. Retrieved from https://idiyas.com/inventor/yu-qian-ft12cj1j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yu Qian - Innovator in Natural Killer Cell Production

Introduction

Yu Qian is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of cellular biology. He has developed innovative methods that enhance the production of natural killer cells, which are crucial for immune responses. His work is particularly relevant in the context of therapeutic applications for various diseases.

Latest Patents

Yu Qian holds a patent for a method titled "Method for producing natural killer cells from pluripotent stem cells." This patent outlines a process for efficiently generating natural killer cells from induced pluripotent stem cells. The method involves culturing pluripotent stem cells in a specialized culture medium to produce CD56+/CD3− immune cells, which are essential for effective immune function. He has 1 patent to his name.

Career Highlights

Yu Qian is currently affiliated with Takeda Pharmaceutical Company Limited, where he continues to advance research in immunology and cell therapy. His work at Takeda emphasizes the importance of innovative approaches to enhance immune cell production, which can lead to breakthroughs in cancer treatment and other immune-related conditions.

Collaborations

Yu has collaborated with notable colleagues, including Hui-Hsin Chang and Xi Shi, who share his commitment to advancing research in the field of immunology. Their combined expertise fosters a collaborative environment that drives innovation and discovery.

Conclusion

In summary, Yu Qian is a key figure in the development of methods for producing natural killer cells, with a focus on enhancing therapeutic applications. His contributions to the field are paving the way for future advancements in immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…